1408. Population Pharmacokinetic (PK) Model to Describe Epithelial Lining Fluid (ELF) Penetration of ASN-1 and ASN-2 after ASN100 Administration to Healthy Subjects

Por Van Wart, Scott A, Stevens, Christopher, Magyarics, Zoltan, Luperchio, Steven A, Rubino, Christopher M, Ambrose, Paul G
Publicado no Open Forum Infect Dis (2018)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

Por Rubino, Christopher M., Van Wart, Scott A., Bhavnani, Sujata M., Ambrose, Paul G., McCollam, Jill S., Forrest, Alan
Publicado em 2009

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

Por Andes, David R., Reynolds, Daniel K., Van Wart, Scott A., Lepak, Alexander J., Kovanda, Laura L., Bhavnani, Sujata M.
Publicado em 2013

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

Por Trang, Michael, Seroogy, Julie D., Van Wart, Scott A., Bhavnani, Sujata M., Kim, Aryun, Gibbons, Jacqueline A., Ambrose, Paul G., Rubino, Christopher M.
Publicado no Antimicrob Agents Chemother (2019)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptoc...

Por Van Wart, Scott A., Ambrose, Paul G., Rubino, Christopher M., Khariton, Tatiana, Riccobene, Todd A., Friedland, H. David, Critchley, Ian A., Bhavnani, Sujata M.
Publicado em 2014

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Por Andes, David, Ambrose, Paul G., Hammel, Jeffrey P., Van Wart, Scott A., Iyer, Varsha, Reynolds, Daniel K., Buell, Donald N., Kovanda, Laura L., Bhavnani, Sujata M.
Publicado em 2011

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

Por Lakota, Elizabeth A., Van Wart, Scott A., Trang, Michael, Tzanis, Evan, Bhavnani, Sujata M., Safir, M. Courtney, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Rubino, Christopher M.
Publicado no Antimicrob Agents Chemother (2020)

Population Pharmacokinetics of Oseltamivir: Pediatrics through Geriatrics

Por Kamal, Mohamed A., Van Wart, Scott A., Rayner, Craig R., Subramoney, Vishak, Reynolds, Daniel K., Bulik, Catharine C., Smith, Patrick F., Bhavnani, Sujata M., Ambrose, Paul G., Forrest, Alan
Publicado em 2013

Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

Por Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
Publicado em 2013

Pharmacokinetic-Pharmacodynamic Analysis for Efficacy of Ceftaroline Fosamil in Patients with Acute Bacterial Skin and Skin Structure Infections

Por Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Drusano, George L., Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
Publicado no Antimicrob Agents Chemother (2014)

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes

Por Schiffer, Joshua T., Swan, David A., Magaret, Amalia, Corey, Lawrence, Wald, Anna, Ossig, Joachim, Ruebsamen-Schaeff, Helga, Stoelben, Susanne, Timmler, Burkhard, Zimmermann, Holger, Melhem, Murad R., Van Wart, Scott A., Rubino, Christopher M., Birkmann, Alexander
Publicado no Sci Transl Med (2016)

Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis

Por Thwaites, Guy E., Bhavnani, Sujata M., Chau, Tran Thi Hong, Hammel, Jeffrey P., Török, M. Estée, Van Wart, Scott A., Mai, Pham Phuong, Reynolds, Daniel K., Caws, Maxine, Dung, Nguyen Thi, Hien, Tran Tinh, Kulawy, Robert, Farrar, Jeremy, Ambrose, Paul G.
Publicado em 2011